MARKET

NBY

NBY

NOVABAY PHARMA
AMEX

Real-time Quotes | Nasdaq Last Sale

0.5729
-0.0001
-0.02%
Opening 12:23 12/11 EST
OPEN
0.5750
PREV CLOSE
0.5730
HIGH
0.5940
LOW
0.5650
VOLUME
99.06K
TURNOVER
--
52 WEEK HIGH
4.040
52 WEEK LOW
0.2290
MARKET CAP
15.98M
P/E (TTM)
-1.2299
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NBY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NBY News

  • NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com
  • Business Wire.12/02 11:50
  • Mid-Afternoon Market Update: Qudian Falls Following Downbeat Q3 Earnings; NovaBay Pharmaceuticals Shares Jump
  • Benzinga.11/18 19:14
  • Mid-Day Market Update: Crude Oil Down 1.9%; Karuna Therapeutics Shares Spike Higher
  • Benzinga.11/18 17:25
  • NovaBay launches NovaSight daily vitamin on Amazon.com; shares up 21% premarket
  • seekingalpha.11/18 17:22

More

Industry

Biotechnology & Medical Research
-0.31%
Pharmaceuticals & Medical Research
-0.02%

Hot Stocks

Name
Price
%Change

About NBY

NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox. Its Avenova with Neutrox removes debris from the skin on the eyelids and lashes without burning or stinging. It develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. Its Aganocide compounds, led by auriclosene (NVC-422), are synthetic molecules with activity against bacteria, viruses and fungi. The Company's dermatology product includes CelleRx, a cleansing solution for post laser resurfacing, chemical peels and other cosmetic surgery procedures. Its wound care business includes the business of NeutroPhase product.
More

Webull offers NovaBay Pharmaceuticals, Inc. (NBY) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.